181 related articles for article (PubMed ID: 9751211)
1. In vitro evaluation of 11C-labeled (S)-nicotine, (S)-3-methyl-5-(1-methyl-2-pyrrolidinyl)isoxazole, and (R,S)-1-methyl-2-(3-pyridyl)azetidine as nicotinic receptor ligands for positron emission tomography studies.
Sihver W; Fasth KJ; Ogren M; Bivehed H; Bergström M; Nordberg A; Watanabe Y; Långström B
J Neurochem; 1998 Oct; 71(4):1750-60. PubMed ID: 9751211
[TBL] [Abstract][Full Text] [Related]
2. In vivo positron emission tomography studies on the novel nicotinic receptor agonist [11C]MPA compared with [11C]ABT-418 and (S)(-)[11C]nicotine in rhesus monkeys.
Sihver W; Fasth KJ; Ogren M; Lundqvist H; Bergström M; Watanabe Y; Långström B; Nordberg A
Nucl Med Biol; 1999 Aug; 26(6):633-40. PubMed ID: 10587101
[TBL] [Abstract][Full Text] [Related]
3. Interaction of the nicotinic agonist (R,S)-3-pyridyl-1-methyl-2-(3-pyridyl)-azetidine (MPA) with nicotinic acetylcholine receptor subtypes expressed in cell lines and rat cortex.
Zhang X; Gong ZH; Fasth KJ; Långström B; Nordberg A
Neurochem Int; 1998; 32(5-6):435-41. PubMed ID: 9676742
[TBL] [Abstract][Full Text] [Related]
4. (S)-3-methyl-5-(1-methyl-2-pyrrolidinyl) isoxazole (ABT 418): a novel cholinergic ligand with cognition-enhancing and anxiolytic activities: I. In vitro characterization.
Arneric SP; Sullivan JP; Briggs CA; Donnelly-Roberts D; Anderson DJ; Raszkiewicz JL; Hughes ML; Cadman ED; Adams P; Garvey DS
J Pharmacol Exp Ther; 1994 Jul; 270(1):310-8. PubMed ID: 7518514
[TBL] [Abstract][Full Text] [Related]
5. An attempt to visualize baboon brain nicotinic receptors with N-[11C]ABT-418 and N-[11C]methyl-cytisine.
Valette H; Bottlaender M; Dollé F; Dolci L; Syrota A; Crouzel C
Nucl Med Commun; 1997 Feb; 18(2):164-8. PubMed ID: 9076773
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and characterization of binding of 5-[76Br]bromo-3-[[2(S)-azetidinyl]methoxy]pyridine, a novel nicotinic acetylcholine receptor ligand, in rat brain.
Sihver W; Fasth KJ; Horti AG; Koren AO; Bergström M; Lu L; Hagberg G; Lundqvist H; Dannals RF; London ED; Nordberg A; Långström B
J Neurochem; 1999 Sep; 73(3):1264-72. PubMed ID: 10461920
[TBL] [Abstract][Full Text] [Related]
7. Characterization of [3H]ABT-418: a novel cholinergic channel ligand.
Anderson DJ; Williams M; Pauly JR; Raszkiewicz JL; Campbell JE; Rotert G; Surber B; Thomas SB; Wasicak J; Arneric SP
J Pharmacol Exp Ther; 1995 Jun; 273(3):1434-41. PubMed ID: 7791118
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and nicotinic acetylcholine receptor in vivo binding properties of 2-fluoro-3-[2(S)-2-azetidinylmethoxy]pyridine: a new positron emission tomography ligand for nicotinic receptors.
Doll F; Dolci L; Valette H; Hinnen F; Vaufrey F; Guenther I; Fuseau C; Coulon C; Bottlaender M; Crouzel C
J Med Chem; 1999 Jun; 42(12):2251-9. PubMed ID: 10377231
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and nicotinic activity of epiboxidine: an isoxazole analogue of epibatidine.
Badio B; Garraffo HM; Plummer CV; Padgett WL; Daly JW
Eur J Pharmacol; 1997 Feb; 321(2):189-94. PubMed ID: 9063687
[TBL] [Abstract][Full Text] [Related]
10. Ligand specificity of nicotinic acetylcholine receptors in rat spinal cord: studies with nicotine and cytisine.
Khan IM; Yaksh TL; Taylor P
J Pharmacol Exp Ther; 1994 Jul; 270(1):159-66. PubMed ID: 8035312
[TBL] [Abstract][Full Text] [Related]
11. 5-substituted derivatives of 6-halogeno-3-((2-(S)-azetidinyl)methoxy)pyridine and 6-halogeno-3-((2-(S)-pyrrolidinyl)methoxy)pyridine with low picomolar affinity for alpha4beta2 nicotinic acetylcholine receptor and wide range of lipophilicity: potential probes for imaging with positron emission tomography.
Zhang Y; Pavlova OA; Chefer SI; Hall AW; Kurian V; Brown LL; Kimes AS; Mukhin AG; Horti AG
J Med Chem; 2004 May; 47(10):2453-65. PubMed ID: 15115389
[TBL] [Abstract][Full Text] [Related]
12. (S)-3-methyl-5-(1-methyl-2-pyrrolidinyl)isoxazole (ABT 418): a novel cholinergic ligand with cognition-enhancing and anxiolytic activities: II. In vivo characterization.
Decker MW; Brioni JD; Sullivan JP; Buckley MJ; Radek RJ; Raszkiewicz JL; Kang CH; Kim DJ; Giardina WJ; Wasicak JT
J Pharmacol Exp Ther; 1994 Jul; 270(1):319-28. PubMed ID: 7913497
[TBL] [Abstract][Full Text] [Related]
13. Nicotinic receptor binding of [3H]cytisine, [3H]nicotine and [3H]methylcarbamylcholine in rat brain.
Anderson DJ; Arneric SP
Eur J Pharmacol; 1994 Mar; 253(3):261-7. PubMed ID: 8200419
[TBL] [Abstract][Full Text] [Related]
14. ABT-594 [(R)-5-(2-azetidinylmethoxy)-2-chloropyridine]: a novel, orally effective analgesic acting via neuronal nicotinic acetylcholine receptors: I. In vitro characterization.
Donnelly-Roberts DL; Puttfarcken PS; Kuntzweiler TA; Briggs CA; Anderson DJ; Campbell JE; Piattoni-Kaplan M; McKenna DG; Wasicak JT; Holladay MW; Williams M; Arneric SP
J Pharmacol Exp Ther; 1998 May; 285(2):777-86. PubMed ID: 9580626
[TBL] [Abstract][Full Text] [Related]
15. Receptor binding characteristics of a 3H-labeled azetidine analogue of nicotine.
Abood LG; Lu X; Banerjee S
Biochem Pharmacol; 1987 Jul; 36(14):2337-41. PubMed ID: 3606644
[TBL] [Abstract][Full Text] [Related]
16. Stable expression, pharmacologic properties and regulation of the human neuronal nicotinic acetylcholine alpha 4 beta 2 receptor.
Gopalakrishnan M; Monteggia LM; Anderson DJ; Molinari EJ; Piattoni-Kaplan M; Donnelly-Roberts D; Arneric SP; Sullivan JP
J Pharmacol Exp Ther; 1996 Jan; 276(1):289-97. PubMed ID: 8558445
[TBL] [Abstract][Full Text] [Related]
17. Epibatidine and ABT 418 reveal selective losses of alpha 4 beta 2 nicotinic receptors in Alzheimer brains.
Warpman U; Nordberg A
Neuroreport; 1995 Nov; 6(17):2419-23. PubMed ID: 8747166
[TBL] [Abstract][Full Text] [Related]
18. Pharmacological characterization of nicotinic receptor-mediated acetylcholine release in rat brain--an in vivo microdialysis study.
Tani Y; Saito K; Imoto M; Ohno T
Eur J Pharmacol; 1998 Jun; 351(2):181-8. PubMed ID: 9687001
[TBL] [Abstract][Full Text] [Related]
19. Synthesis of (S)-N-[methyl-11C]nicotine and its regional distribution in the mouse brain: a potential tracer for visualization of brain nicotinic receptors by positron emission tomography.
Saji H; Magata Y; Yamada Y; Tajima K; Yonekura Y; Konishi J; Ohmomo Y; Yokoyama A
Chem Pharm Bull (Tokyo); 1992 Mar; 40(3):734-6. PubMed ID: 1611685
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and in vitro and in vivo evaluation of [11C]methyl-BIII277CL for imaging the PCP-binding site of the NMDA receptor by pet.
Kokic M; Honer M; Kessler LJ; Grauert M; Schubiger PA; Ametamey SM
J Recept Signal Transduct Res; 2002; 22(1-4):123-39. PubMed ID: 12503611
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
